A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative ImmunogenicityMatthew D. J. Dicks, Matthew G. Cottingham, Nick J. Edwards et al.|PLoS ONE|2012Cited by 398
Long-Term Thermostabilization of Live Poxviral and Adenoviral Vaccine Vectors at Supraphysiological Temperatures in Carbohydrate GlassRobert Alcock, Adrian V. S. Hill, David Wyllie et al.|Science Translational Medicine|2010Cited by 166
Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in miceAlexandra J. Spencer, Teresa Lambe|Nature Communications|2021Cited by 137
Recombination-Mediated Genetic Engineering of a Bacterial Artificial Chromosome Clone of Modified Vaccinia virus Ankara (MVA)Matthew G. Cottingham, Sarah C. Gilbert, Rikke Fredslund Andersen et al.|PLoS ONE|2008Cited by 93
Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley Fever vaccine in miceGeorge M. Warimwe, Sarah C. Gilbert, Amar Lall et al.|Virology Journal|2013Cited by 60